Recent findings have also demonstrated that SARS-CoV-2 IgA antibodies can persist for over 6 months following infection (16, 32–34), suggesting that quantifying IgA antibodies may potentially be beneficial to sero-surveillance studies and add to its overall sensitivity in identifying past infections. The gene discussed is CD79A; the disease is infection.